Infections with high-risk human papillomaviruses (HPVs) are causative events for cervical cancer, and subgroups of other anogenital cancers. In the course of various projects, we are studying the impact of this finding at the level of cancer prevention, diagnostics, risk stratification, test of cure, and prophylactic vaccination.